TONIX PHARMACEUTICALS HOLDING CORP. Preferred Stock, Value, Issued
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Preferred Stock, Value, Issued of $0 as of 2016-03-31, per its 10-Q filed 2016-05-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2016-05-06
- 2016-03-31: Preferred Stock, Value, Issued $0.00.
- 2015-12-31: Preferred Stock, Value, Issued $0.00.
- 2015-09-30: Preferred Stock, Value, Issued $0.00.
- 2015-06-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-06 |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-06 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-03 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-13 |
| 2011-12-31 | $0.00 10-K/A · filed 2013-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |